The International Generic and Biosimilar Medicines Association (IGBA) announced today that it has appointed a Chair and Vice-Chair for its newly established Committee. Richard Saynor, CEO Sandoz, has been nominated as inaugural Chair, and Vinita Gupta, CEO Lupin, has been appointed Vice-Chair, both effective January 1, 2023, for a term of one year.
- Generic and Biosimilar Medicines, Central to Patient Health and Global Healthcare Policies (September 2022)
- ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine (28 July 2022)
- UICC announces a new global coalition to increase access to and the use of essential cancer medicines in low- and lower middle-income countries (May 2022)
- IGBA’s Newly Launched CEO Advisory Committee Holds Inaugural Meeting with WTO Director General (May 2022)
